Artwork

Content provided by Ketamine Wellness Centers. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ketamine Wellness Centers or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

A Closer Look at Spravato (Esketamine) - What will the drug cost and will insurance cover it?

11:05
 
Share
 

Manage episode 229190432 series 1756689
Content provided by Ketamine Wellness Centers. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ketamine Wellness Centers or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention. This episode focuses on the cost of Spravato to the provide, end user, and insurer: - What are the preliminary cost estimates for Spravato (wholesale) - Can we estimate the cost to the patient? - Will insurance cover the drug? - How will the treatment schedule effect the cost? www.ketaminewellnesscenters.com/category/podcast/
  continue reading

15 episodes

Artwork
iconShare
 
Manage episode 229190432 series 1756689
Content provided by Ketamine Wellness Centers. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ketamine Wellness Centers or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention. This episode focuses on the cost of Spravato to the provide, end user, and insurer: - What are the preliminary cost estimates for Spravato (wholesale) - Can we estimate the cost to the patient? - Will insurance cover the drug? - How will the treatment schedule effect the cost? www.ketaminewellnesscenters.com/category/podcast/
  continue reading

15 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide